论文部分内容阅读
应用国产吲哚菁绿(ICG)检测健康对照组如例,肝脏疾病86例(药物性肝损6例,肝癌8例,急性肝炎12例,慢性迁延性肝炎12例,慢性活动性肝炎18例,肝硬化30例,阳性率分别为33.3%、75%、16.6%、25%,72.2%、93.3%)。肝硬化组明显高于正常对照组(P<0.05)。20例半年后复查 ICG 随病情的变化而改变,定期复查对肝脏疾病的预后判断病变的进展及指导治疗有十分重要的价值。
Application of indocyanine green (ICG) test of healthy control group, for example, 86 cases of liver disease (drug-induced liver damage in 6 cases, 8 cases of liver cancer, 12 cases of acute hepatitis, 12 cases of chronic persistent hepatitis, 18 cases of chronic active hepatitis , 30 cases of cirrhosis, the positive rates were 33.3%, 75%, 16.6%, 25%, 72.2%, 93.3% respectively). Liver cirrhosis group was significantly higher than the normal control group (P <0.05). Sixty cases of ICG were reviewed after six months. The ICG changed with the changes of the disease. It is very important to review the prognosis of the liver disease to judge the progress of the disease and to guide the treatment regularly.